Navigation Links
ESHRE's annual meeting -- press program
Date:6/24/2013

The annual meeting of ESHRE, the world's leading event in reproductive medicine, is only weeks away - and the press programme almost complete. Once again the meeting promises one of the best sources of news and features in fertility and reproductive medicine. This year's event will take place in London from 7-10th July.

More than 9000 of the world's leading experts in reproduction are expected this year, and, from a total of 1600 abstracts of new research submitted, ten have been selected for the press programme.

The programme will comprise ten press releases (issued under embargo a few days in advance) and a news briefing on two of the three congress days. Here, investigators will describe their research and answer press questions on its scientific and public health implications.

Topics to be covered include:

  • successful embryo selection for IVF with new genome sequencing technique
  • the motivation of egg donors in European clinics (altruism or money?)
  • in utero and early life influences on male fertility
  • environmental pollution and its effects on IVF outcome
  • IVF for 200 euro per cycle: ready for developing countries?
  • cancer risk in IVF children
  • the women who store their eggs for fertility preservation
  • shift working and its effect on reproductive outcomes
  • how obesity affects the implantation potential of the uterus

The news briefings will take place at 9.30 am on Monday 8th July and Tuesday 9th July. Each news briefing will cover four topics, with short presentations from investigators and time for questions.

A preview briefing of all the press releases will be held on Friday 5th July at 10.00 am at the Science Media Centre in Lo ndon (215 Euston Road, London NW1 2BE). All press releases will be available (on paper and under embargo) at this briefing, with comment from UK and ESHRE experts.

Press releases under embargo will be distributed electronically on Saturday 6th July, and will be openly available on the ESHRE website (http://www.eshre.eu) once the embargoes have lifted. One press release suitably embargoed has been selected for Monday publications and will be previewed in detail by the principal investigator at the Friday morning briefing.

ESHRE welcomes journalists to the meeting, and a serviced press room with support materials and wi-fi connection will be available. Registration is free to bona fide journalists on presentation of official press credentials.

ESHRE's media policy requires accreditation with a recognised press card or commissioning letter from an editor confirming the assignment. Before seeking registration, you should check ESHRE's media policy, which is accessible at http://www.eshre2013.eu/~/media/Files/London/Media%20Policy%20%20ESHRE%202013.pdf

Registration in advance is recommended, but journalists may register on site provided that press credentials are provided with a formally recognised press card and/or a commissioning letter from a recognised media organisation. Business cards are not acceptable.

The official congress language is English. There are no simultaneous translations.


'/>"/>

Contact: Christine Bauquis
christine@eshre.eu
32-049-925-8046
European Society of Human Reproduction and Embryology
Source:Eurekalert

Related biology news :

1. Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012
2. Registration open for the Ecological Society of Americas 2012 Annual Meeting in Portland, Ore.
3. 5th Annual Advances in Biomolecular Engineering Symposium
4. 2012 ARVO Award recipients honored at annual meeting
5. Cracking the Neural Code: Third Annual Aspen Brain Forum
6. DOE Plasma Science Center Annual Meeting at Princeton Plasma Lab
7. 6th Annual Canadian Neuroscience Meeting, Vancouver, May 20-23, 2012
8. European Society of Human Reproduction and Embryology 28th Annual Meeting -- Istanbul
9. BioMed Central announces winners of 6th Annual Research Awards
10. John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
11. MARC travel awards announced for the Society for Developmental Biology 71st Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/1/2016)... , February 1, 2016 ... advancements to drive global touchfree intuitive gesture control market ... --> Rising sales of consumer electronics coupled with ... control market size through 2020 ... electronics coupled with new technological advancements to drive global ...
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... International, a not-for-profit organization focused on the ethics and governance ... to patients around the world, today announced that the editors ... the Good Pharma Scorecard an ,Editors, Pick, ... of BMJ Open ,s ,Most Popular Articles, which includes ... read. Ed Sucksmith , assistant editor of ...
(Date:2/11/2016)... BEACH, Florida , February 11, 2016 /PRNewswire/ ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), ... diagnostics, announced today that its Thermomedics subsidiary, which ... progress on its growth plan in January 2016, ... products distributors, increasing sequential monthly sales growth, and ...
(Date:2/10/2016)... MONTREAL , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. ... is pleased to announce that Mitsui & Co. Ltd., ... bio-based succinic acid plant, is investing an additional CDN$25 ... equity, increasing its stake from 30% to 40%.  Mitsui ... of bio-succinic acid produced in Sarnia ...
(Date:2/10/2016)... York, New York (PRWEB) , ... ... ... Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the Human ... and immunotherapies for infectious diseases and cancer. , The Human Vaccines ...
Breaking Biology Technology: